all-trans-retinol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases all-cause mortality
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“At longest follow-up, there was a 12% observed reduction in the risk of all-cause mortality for VAS compared with control using a fixed-effect model (risk ratio (RR) 0.88, 95% confidence interval (CI) 0.83 to 0.93; high-certainty evidence).”
Quoted verbatim from Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.. - Study
- meta-analysis
- Population
- Children aged six months to five years living in the community; 19 pooled randomised trials of synthetic vitamin A supplementation versus control; hospital and diseased children excluded
Effect 0.88 risk ratio, 95% CI 0.83 to 0.93
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.2022PMID:35294044Permalink
Keep reading
- Everything the graph holds on all-trans-retinol
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PSYP3V10J8QHJ19DBQB3XX